Taking Stock Of Stocks

Bringing precision medicine to the masses

The Sunday Times and the Singapore Exchange's research team interview company bosses to help investors get a view of a firm's operations and strategic direction - aspects that go beyond the financials. We speak to Clearbridge Health executive director and chief executive Jeremy Yee to get his insights on the firm.

Executive director and CEO Jeremy Yee has seen Clearbridge Health grow from just two clinics in 2017 to a network of medical clinics/ centres and healthcare systems in Singapore, Malaysia, Hong Kong and the Philippines.
Executive director and CEO Jeremy Yee has seen Clearbridge Health grow from just two clinics in 2017 to a network of medical clinics/ centres and healthcare systems in Singapore, Malaysia, Hong Kong and the Philippines. ST FILE PHOTO
New: Gift this subscriber-only story to your friends and family

Clearbridge Health is an Asia-focused healthcare precision medicine service provider that listed on the Singapore Exchange's Catalist board in December 2017.

It was set up in 2010 in Singapore and known then as Clearbridge Accelerator. The firm invested in medical technology and incubated global deep-technology healthcare firms.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Sunday Times on April 28, 2019, with the headline Bringing precision medicine to the masses. Subscribe